Literature DB >> 24565640

Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.

D Leo1, L Mus2, S Espinoza3, M C Hoener4, T D Sotnikova5, R R Gainetdinov6.   

Abstract

Trace Amine-Associated Receptor 1 (TAAR1) is a G protein-coupled receptor (GPCR) expressed in several mammalian brain areas and activated by "trace amines" (TAs). TAs role is unknown; however, discovery of their receptors provided an opportunity to investigate their functions. In vivo evidence has indicated an inhibitory influence of TAAR1 on dopamine (DA) neurotransmission, presumably via modulation of dopamine transporter (DAT) or interaction with the D2 DA receptor and/or activation of inwardly rectifying K(+) channels. To elucidate the mechanisms of TAAR1-dependent modulation, we used TAAR1 knockout mice (TAAR1-KO), a TAAR1 agonist (RO5166017) and a TAAR1 antagonist (EPPTB) in a set of neurochemical experiments. Analysis of the tissue content of TAAR1-KO revealed increased level of the DA metabolite homovanillic acid (HVA), and in vivo microdialysis showed increased extracellular DA in the nucleus accumbens (NAcc) of TAAR1-KO. In fast scan cyclic voltammetry (FSCV) experiments, the evoked DA release was higher in the TAAR1-KO NAcc. Furthermore, the agonist RO5166017 induced a decrease in the DA release in wild-type that could be prevented by the application of the TAAR1 antagonist EPPTB. No alterations in DA clearance, which are mediated by the DAT, were observed. To evaluate the interaction between TAAR1 and D2 autoreceptors, we tested the autoreceptor-mediated dynamics. Only in wild type mice, the TAAR1 agonist was able to potentiate quinpirole-induced inhibitory effect on DA release. Furthermore, the short-term plasticity of DA release following paired pulses was decreased in TAAR1-KO, indicating less autoinhibition of D2 autoreceptors. These observations suggest a close interaction between TAAR1 and the D2 autoreceptor regulation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dopamine (DA); Dopamine receptor 2 (D2R); Fast scan cyclic voltammetry (FSCV); Neuropsychiatric disorders; Schizophrenia; Trace amine-associate receptor 1 (TAAR1)

Mesh:

Substances:

Year:  2014        PMID: 24565640     DOI: 10.1016/j.neuropharm.2014.02.007

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  57 in total

Review 1.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

Review 2.  Dopamine receptors - IUPHAR Review 13.

Authors:  Jean-Martin Beaulieu; Stefano Espinoza; Raul R Gainetdinov
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

3.  Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists.

Authors:  Guido Galley; Angélica Beurier; Guillaume Décoret; Annick Goergler; Roman Hutter; Susanne Mohr; Axel Pähler; Philipp Schmid; Dietrich Türck; Robert Unger; Katrin Groebke Zbinden; Marius C Hoener; Roger D Norcross
Journal:  ACS Med Chem Lett       Date:  2015-12-30       Impact factor: 4.345

4.  Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity.

Authors:  Nicholas B Miner; Josh S Elmore; Michael H Baumann; Tamara J Phillips; Aaron Janowsky
Journal:  Neurotoxicology       Date:  2017-09-15       Impact factor: 4.294

Review 5.  Commonalities and Distinctions Among Mechanisms of Addiction to Alcohol and Other Drugs.

Authors:  Angela R Ozburn; Aaron J Janowsky; John C Crabbe
Journal:  Alcohol Clin Exp Res       Date:  2015-10       Impact factor: 3.455

6.  TAAR1 Modulates Cortical Glutamate NMDA Receptor Function.

Authors:  Stefano Espinoza; Gabriele Lignani; Lucia Caffino; Silvia Maggi; Ilya Sukhanov; Damiana Leo; Liudmila Mus; Marco Emanuele; Giuseppe Ronzitti; Anja Harmeier; Lucian Medrihan; Tatyana D Sotnikova; Evelina Chieregatti; Marius C Hoener; Fabio Benfenati; Valter Tucci; Fabio Fumagalli; Raul R Gainetdinov
Journal:  Neuropsychopharmacology       Date:  2015-03-09       Impact factor: 7.853

Review 7.  TAAR1 and Psychostimulant Addiction.

Authors:  Jianfeng Liu; Ruyan Wu; Jun-Xu Li
Journal:  Cell Mol Neurobiol       Date:  2020-01-23       Impact factor: 5.046

Review 8.  Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders.

Authors:  Richard M Kostrzewa; Karolina Wydra; Malgorzata Filip; Cynthia A Crawford; Sanders A McDougall; Russell W Brown; Dasiel O Borroto-Escuela; Kjell Fuxe; Raul R Gainetdinov
Journal:  J Pharmacol Exp Ther       Date:  2018-06-19       Impact factor: 4.030

9.  TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking.

Authors:  Jianfeng Liu; Bernard Johnson; Ruyan Wu; Robert Seaman; Jimmy Vu; Qing Zhu; Yanan Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2020-05-05       Impact factor: 8.739

10.  Trace Amine-Associated Receptor 1 Regulates Wakefulness and EEG Spectral Composition.

Authors:  Michael D Schwartz; Sarah W Black; Simon P Fisher; Jeremiah B Palmerston; Stephen R Morairty; Marius C Hoener; Thomas S Kilduff
Journal:  Neuropsychopharmacology       Date:  2016-09-23       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.